Clexance 6000IU/0.6ml

Enoxaparin Sodium, a low molecular weight heparin, stands as an anticoagulant medication used for the prevention and treatment of various thromboembolic disorders, including deep vein thrombosis (DVT), pulmonary embolism (PE), and acute coronary syndrome (ACS). Its mechanism of action involves binding to antithrombin III and potentiating its inhibitory effect on factor Xa, thereby inhibiting the conversion of prothrombin to thrombin and preventing the formation of blood clots.

One of the standout features of Enoxaparin Sodium is its efficacy in preventing thromboembolic events in individuals at risk, such as those undergoing surgery, hospitalized patients, and individuals with acute coronary syndromes. Additionally, Enoxaparin Sodium offers a predictable anticoagulant effect, allowing for weight-based dosing and reduced risk of bleeding complications compared to unfractionated heparin. Moreover, Enoxaparin Sodium is available in prefilled syringes for subcutaneous administration, offering convenience and ease of use for both healthcare providers and patients.